BDBM114613 1-[(5-bromanylthiophen-2-yl)methyl]-4-pyridin-2-yl-piperazine::1-[(5-bromo-2-thienyl)methyl]-4-(2-pyridyl)piperazine::1-[(5-bromo-2-thiophenyl)methyl]-4-(2-pyridinyl)piperazine::1-[(5-bromothiophen-2-yl)methyl]-4-pyridin-2-ylpiperazine::SR-01000202086::SR-01000202086-3::cid_2838302

SMILES C=CC(=O)N1CC2(CC(c3nc(-c4ccc5c(c4)c(C)nn5C)c(-c4c(C)ccc5[nH]ncc45)n3C)C2)C1

InChI Key InChIKey=YBLRRRKATMWSKQ-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 114613   

TargetGTPase KRas [G12C](Human)
Jazz Pharmaceuticals Ireland

US Patent
LigandChemical structure of BindingDB Monomer ID 114613BDBM114613(1-[6-[4-(1,3-dimethylindazol-5-yl)-1-methyl-5-(5-m...)
Affinity DataIC50: 5.50E+3nMAssay Description:NIH Molecular Libraries Screening Centers Network [MLSCN] Emory Chemical Biology Discovery Center in MLSCN Assay provider: Dr. Randal Kaufman, Univer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/12/2011
Entry Details
PCBioAssay